tiprankstipranks
Recursion Pharmaceuticals (RXRX)
NASDAQ:RXRX
US Market

Recursion Pharmaceuticals (RXRX) Cash flow

986 Followers

Recursion Pharmaceuticals Cash Flow

RXRX's free cash flow for Q3 2023 was $―. For the 2023 fiscal year, RXRX's free cash flow was decreased by $77.53M and operating cash flow was $-72.92M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -258.45M$ -83.52M$ -158.61M$ -45.40M$ -57.04M
Investing Cash Flow
$ -15.72M$ 193.25M$ -271.74M$ -8.74M$ -3.91M
Financing Cash Flow
$ 206.73M$ 154.34M$ 458.54M$ 246.13M$ 120.41M
Cash Flow From Discontinued Operation
-----
Other Cash Adjustment Inside Changein Cash
-----
End Cash Position
$ 1.85B$ 559.11M$ 295.35M$ 267.17M$ 75.17M
Income Tax Paid Supplemental Data
-----
Interest Paid Supplemental Data
$ 49.00K$ 55.00K$ 680.00K$ 989.00K$ 485.00K
Issuance Of Capital Stock
$ 193.71M$ 143.71M$ 462.90M$ 239.13M$ 119.92M
Issuance Of Debt
$ -95.00K$ -90.00K$ -12.80M$ 6.40M$ 11.89M
Repayment Of Debt
$ -71.00K$ -90.00K$ -12.80M$ -77.00K$ -11.18M
Free Cash Flow
$ -202.82M$ -120.88M$ -198.41M$ -52.13M$ -60.95M
Domestic Sales
-----
Foreign Sales
-----
Currency in USD

Recursion Pharmaceuticals Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis